Clinical trial
Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
NCT01935622 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- June 30, 2014
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-ischemic cardiomyopathy, systolic heart failure (nyha ii-iii)